What is the layman's term for lipoprotein(a)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Layman's Term for Lipoprotein(a)

There is no widely accepted layman's term for lipoprotein(a)—it is simply referred to as "Lp(a)" or "lipoprotein(a)" in both medical and patient communication. 1

What Lipoprotein(a) Actually Is

When explaining to patients, lipoprotein(a) can be described as:

  • A special type of cholesterol particle that consists of an LDL-like (bad cholesterol) particle attached to a unique protein called apolipoprotein(a) 2

  • A genetic cholesterol variant that is inherited and remains stable throughout life, unaffected by diet, exercise, or most cholesterol medications 3, 4

  • "Sticky cholesterol" is sometimes used informally to convey its pro-inflammatory and pro-thrombotic properties, though this is not an official medical term 5, 6

Standardized Nomenclature

The NHLBI Working Group established formal naming conventions:

  • The lipoprotein should be called "Lipoprotein(a)" or "Lp(a)" with no space between lipoprotein and (a) 1

  • Patients with elevated levels should be described as having "Elevated Lp(a)" or "Hyperlipoproteinemia(a)" 1

  • Traditional thresholds for elevated Lp(a) are >30 mg/dL or >75 nmol/L, which approximate the 75th percentile in white populations 1

Clinical Communication Approach

When discussing with patients:

  • Emphasize that Lp(a) is primarily genetically determined and affects 20-30% of the global population (over one billion people worldwide) 1

  • Explain it as an independent risk factor for heart disease and stroke that is 5-6 times more atherogenic than regular LDL cholesterol on an equimolar basis 5

  • Clarify that one lifetime measurement is sufficient since levels remain stable throughout life 4, 7, 8

  • Note that standard cholesterol medications don't effectively lower it, but new targeted therapies are in development 3, 7, 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.